Heart Failure Pharmacology
Sort by:
Houston Methodist DeBakey Heart and Vascular Center
Novel Therapies in Heart Failure
FEATURING
Nadia Fida
- 718 views
- February 10, 2023
- 6
Top Ten Topics in Clinical Cardiology 2022
Time to Erase Boundary Between HFrEF & HFpEF? At Least Therapeutics Suggest So!
FEATURING
Biykem Bozkurt
- 492 views
- November 21, 2022
- 3
Scripps Health
Heart Failure: Guideline Based and Novel Therapies
FEATURING
Rola Khedraki
- 1,101 views
- June 13, 2023
- 11
American College of Cardiology
Voyager PAD Trial: How Effective Is Rivaroxaban for Patients with Lower Extremity PAD Undergoing Revascularization?
FEATURING
Peter Block,
Deepak Bhatt
- 1,852 views
- October 22, 2020
- 6
Arun Kochar
Heart Failure Management – Newer Treatment Paradigms
FEATURING
Arun Kochar
- 437 views
- August 5, 2020
- 6
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Amyloidosis I: Advances Detecting and Differentiating Disease Types
FEATURING
Marcus Urey
- 334 views
- January 30, 2020
- 1
Houston Methodist DeBakey Heart and Vascular Center
Tips and Tricks for Medical Optimization of HF in the Clinic
FEATURING
Ashrith Guha
- 1,570 views
- March 5, 2022
- 6
Courage and Innovation Symposium: Heart Failure & Heart Transplantation
Updates on Cardiac Amyloidosis: A “Rare” Disease Hiding in Plain Sight
FEATURING
Nitasha Sarswat
- 1,261 views
- April 27, 2022
- 13
Cedars Sinai
SGLT2 Inhibitors: Are They the Modern-Day Statins? Insights from Recent Cardiorenal Metabolic Outcome Trial
FEATURING
Sanjay Kaul,
Milton Packer
- 1,785 views
- February 7, 2022
- 9
VuMedi Webinars
Heart Failure: Latest Treatment Advances
Faculty: Thomas Heywood, Daniel Burkhoff, John R. Teerlink, Akshay Desai, Peter Pang
- 5,142 views
- June 22, 2017
- 9
Scripps Health
Treatment of ATTR-CM: New Drugs on the Horizon
FEATURING
Julie Rosenthal
- 843 views
- November 15, 2021
- 11
Cardiovascular Disease Management - 5th Annual Symposium
What’s New in Heart Failure Treatment? What Role Do the New Agents Have?
FEATURING
Uri Elkayam
- 1,132 views
- December 27, 2017
- 3
American Heart & Vascular Institute
Q&A: Understanding SGLT-2 Inhibitors in the CardioNephroEndo Space
- 503 views
- September 9, 2021
Yale School of Medicine
ACC 21 Highlights: Angiotensin Receptor Neprilysin Inhibition Following Acute MI (PARADISE-MI) Trial
FEATURING
Rohan Khera
- 340 views
- June 14, 2021
- 1
American Heart & Vascular Institute
Heart Failure With Reduced Ejection Fraction: New Therapies on the Horizon
FEATURING
Nasrien Ibrahim
- 1,163 views
- September 16, 2021
- 9
Heart Failure 2021: An Update on Therapy
Use of Diuretics in Patients With Volume Overload: What to Do When You See Diuretic Resistance?
FEATURING
Jeffrey Testani
- 644 views
- March 30, 2021
- 11
16th Annual Heart Failure Holiday Symposium
New Treatment Approaches to HFrEF: When to Use SGLT2, Vericiguat, Omecamtiv Mecarbil and IV Iron?
FEATURING
Mark Drazner
- 1,116 views
- February 18, 2021
- 12